or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    GRI F GRI Bio, Inc. 0.20
    HEPA F Hepion Pharmaceuticals, Inc. -3.82
    BFRG F Bullfrog AI Holdings, Inc -3.02
    GILD F Gilead Sciences, Inc. 2.14
    ALGS F Aligos Therapeutics, Inc. -5.95
    MIRM F Mirum Pharmaceuticals, Inc. -4.14
    NTLA F Intellia Therapeutics, Inc. -1.61
    GYRE D Gyre Therapeutics, Inc. -2.69
    TARA D ArTara Therapeutics, Inc. 0.67
    ALNY C Alnylam Pharmaceuticals, Inc. -0.59
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Medicine Biopharmaceutical Hepatitis Hepatitis B Non Alcoholic Fatty Liver Disease Steatohepatitis Amyloid Amyloidosis Antitrypsin Deficiency Biotechnology Chronic Liver Diseases Coronavirus Gilead Sciences Hepatology Hepatotoxins Immune System Lipid Pulmonary Arterial Hypertension Tenofovir Disoproxil Transthyretin

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    IBBQ B Invesco Nasdaq Biotechnology ETF 10.07
    IBB C iShares Nasdaq Biotechnology Index Fund 9.95
    BBH B Market Vectors Biotech ETF 9.41
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.01
    GNOM D Global X Genomics & Biotechnology ETF 8.07
    View all Liver Disease ETFs...
    Compare ETFs
    Compare IBBQ to BBH Compare IBBQ to GNOM Compare IBBQ to IBB

        Liver Disease Stocks Recent News

        Date Stock Title
        May 10 GRI GRI Bio files for $75M mixed shelf
        May 10 NTLA Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
        May 10 MIRM Mirum Pharmaceuticals Inc (MIRM) Q1 2024 Earnings: Misses Revenue Forecasts, Posts Wider Net Loss
        May 10 NTLA Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
        May 10 NTLA Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
        May 10 GYRE Gyre Therapeutics GAAP EPS of $0.03, revenue of $27.17M
        May 10 NTLA Intellia Therapeutics First Quarter 2024 Earnings: Beats Expectations
        May 10 NTLA Q1 2024 Intellia Therapeutics Inc Earnings Call
        May 9 GILD Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
        May 9 GYRE Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
        May 9 GILD Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 MIRM Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of Estimates
        May 9 NTLA Intellia Therapeutics, Inc. (NTLA) Q1 2024 Earnings Call Transcript
        May 9 GILD Gilead's FOCUS Program Helps Zero In on Early HIV Detection
        May 9 NTLA Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
        May 9 MIRM Q1 2024 Mirum Pharmaceuticals Inc Earnings Call
        May 9 NTLA Intellia Therapeutics GAAP EPS of -$1.12 beats by $0.25, revenue of $28.94M beats by $19.87M
        May 9 NTLA Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
        May 9 MIRM Mirum Pharmaceuticals Inc (MIRM) Q1 2024 Earnings Call Transcript Highlights: Soaring Sales and ...
        May 9 GILD Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Hepatitis Medicine Non Alcoholic Fatty Liver Disease Steatohepatitis Biopharmaceutical Alcohol Hepatology Amyloid Amyloidosis Antitrypsin Deficiency Biotechnology Clinical Medicine Coronavirus Drug Development Hepatitis B Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Transthyretin
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags